OMB control number
Disease Awareness and Prescription Drug Promotion on Television
OMB 0910-0874 · HHS/FDA.
OMB 0910-0874
This research concerns disease awareness and prescription drug promotion communications on television. When pharmaceutical companies market a new drug, they often also release disease awareness communications about the medical condition the new drug is intended to treat. FDA is interested in whether and to what extent this practice may result in consumers confusing or otherwise misinterpreting the different information and claims presented in disease awareness communications and prescription drug promotion. We propose two studies designed to provide insights on this topic.
The latest form for Disease Awareness and Prescription Drug Promotion on Television expires 2021-08-31 and is listed under ICR 202001-0910-014.
Latest Forms, Documents, and Supporting Material
| Document | Type |
|---|---|
 0874 OMB Justification Memo 2020.docx | Justification for No Material/Nonsubstantive Change |
| 0874 Supporting Statement Part B 2020.docx | Supporting Statement B |
| Supporting Statement Part A Disease Awareness and PDP on TV 2019.docx | Supporting Statement A |
 Study 2 |
Other-Survey Instrument |
| Study 1 |
Other-Survey Instrument |
| Study 2 - Pretest |
Other-Survey Instrument |
| Study 1 - Pretest |
Other-Survey Instrument |
| Study 2 - Screener |
Other-Screeners |
| Study 1 - Screener |
Other-Screener |
| Study 2 - Pretest Screener |
Other-Screeners |
| Study 1 - Pretest Screener |
Other-Screeners |
All Historical Document Collections
| Reference | Filing | Received | Concluded | Action |
|---|---|---|---|---|
| 202001-0910-014 | No material or nonsubstantive change to a currently approved collection | 2020-01-28 | Approved without change | |
| 201906-0910-011 | New collection (Request for a new OMB Control Number) | 2019-06-28 | Approved without change |
OMB Details
Study 1 - Pretest Screener
Federal Enterprise Architecture: Health - Consumer Health and Safety